Case Study

The challenge

Rapidly scaling a genomic research initiative with results that can be integrated into clinical care for a large population in Nevada.

As part of the expansion of the Healthy Nevada Project (HNP), Renown Health Institute for Health Innovation (Renown IHI) sought to engage 40,000 Nevadans in a large scale genomics research initiative that would drive novel discoveries as well as improve clinical care.

This meant that, in addition to needing participant friendly engagement tools, they needed next-generation sequencing technology that could produce clinical-grade data at scale. Historically, this would have required coordinating with multiple partners.

About Renown IHI

More details

About Renown IHI

Renown Institute for Health Innovation (Renown IHI) is a collaboration between Renown Health – a locally governed and locally owned, not-for-profit integrated healthcare network serving Nevada, Lake Tahoe and northeast California; and the Desert Research Institute – a recognized world leader in investigating the effects of natural and human-induced environmental change and advancing technologies aimed at assessing a changing plane.

About the Healthy Nevada Project

More details

About the Healthy Nevada Project

The Healthy Nevada Project is a population health study run by Renown IHI. The goal is to understand factors that determine health outcomes—one of which is genetics. They hope to learn about how your genetics impact your personal health trajectory and use this information to help you make better decisions about your health.

Helix services used

More details

Helix services used

  • One of the world’s largest CLIA-certified, CAP-accredited next-generation sequencing labs
  • Exome+™: a panel-grade medical exome enhanced by more than 300,000 informative non-coding regions
  • Co-branded ancestry + traits DNA product for all participants
  • Secure storage of genomic data for the lifetime of the participant
  • Infrastructure and data to facilitate research
  • In-house clinical and scientific expertise

The solution

Combining Renown IHI’s expertise in healthcare and research with Helix’s end-to-end population 
health solution.

Renown IHI worked closely with Helix to customize its end-to-end population health solution. Helix's participant-facing engagement tools, in-house clinical and scientific expertise, clinical-grade Exome+™ assay, and next-generation sequencing lab (one of the world's largest) provided this project with powerful tools that helped it become one of the fastest growing population sequencing initiatives in the United States.

More than an exome

Each participant’s DNA was sequenced using the Exome+™ assay—far surpassing the amount of data collected in other comparable initiatives—enabling Renown IHI to deliver actionable insights to their patients and to be a leading innovator in precision health. Additionally, the Exome+ assay covers the entire exome plus more than 300,000 informative non-coding regions that are available to help participants (and their physicians) continue learning from their DNA over time.

Helix's end-to-end solution is powering one of the fastest growing population genomics initiatives in the United States

CLIA/CAP
next-generation
sequencing lab

Proprietary
Exome+ assay

Participant-facing
engagement tools

Sequence once,
query often model

The results

In less than one year, Renown IHI has assembled one of the largest genomic and health data sets in the world and changed the standard of care in their community.

UNPRECEDENTED PACE

10,000

Sign-ups in the first four days

>20,000

People recruited, sequenced, and given results in less than 6 months

250,000

Participants targeted in expansion plan

MEASURABLE CLINICAL IMPACT

1.3%

received actionable medical results across 3 conditions:

Familial hypercholesterolemia

Lynch syndrome

Hereditary breast and ovarian cancer syndrome

90%

would have been missed under current medical practice

26%

had already developed indications of disease

COMMUNITY ENGAGEMENT

RESEARCH ADVANCEMENT

Contact us to learn how Helix can enable your population health initiative

*Required fields

References

1
Grzymski JJ, et al. Population Health Genetic Screening for Tier 1 Inherited Diseases in Northern Nevada: 90% of At-Risk Carriers are Missed. BioRxiv Preprint.
May. 27, 2019; doi: http://dx.doi.org/10.1101/650549.
2
Cirulli E.T. Genome-wide rare variant analysis for thousands of phenotypes in 54,000 exomes.
BioRxiv Preprint. Jul. 4, 2019; doi: http://dx.doi.org/10.1101/692368